Add BrightSurf on Google Email

University of California - San Diego


Fat-cell hormone linked to kidney disease

Researchers at UC San Diego School of Medicine found that low levels of adiponectin, a hormone produced by fat cells, are linked to elevated albumin protein in the urine and increased inflammation in the kidney. The study suggests that supplementing with adiponectin or other therapies may help protect kidney function in obese patients.

SourceUniversity of California - San Diego·JournalJournal of Clinical Investigation·DateApr 22, 2008

MRI: A window to genetic properties of brain tumors

Researchers have shown that MRI can non-invasively characterize brain tumors and determine which are responsive to specific treatments based on their molecular properties. The study identified five distinct MRI features linked with particular gene expression patterns, including those associated with tumor proliferation and growth.

SourceUniversity of California - San Diego·JournalProceedings of the National Academy of Sciences·DateMar 24, 2008

Biologists at UC San Diego identify key protein in cell's 'self-eating' function

UC San Diego researchers have identified a novel protein called Atg30 that controls peroxisome degradation, a process linked to cell growth, aging, and homeostasis. The discovery allows scientists to control this aspect of cellular autophagy, potentially leading to new insights into aging, immunity, neurodegeneration, and cancer.

SourceUniversity of California - San Diego·JournalDevelopmental Cell·DateMar 11, 2008

New UC analysis shows alarming increase in expected growth of China's carbon dioxide emissions

A new analysis by economists at the University of California, Berkeley and UC San Diego shows a significant increase in China's carbon dioxide emissions growth, far surpassing previous estimates. The study predicts an annual growth rate of at least 11 percent for China between 2004 and 2010.

SourceUniversity of California - San Diego·JournalJournal of Environmental Economics and Management·DateMar 10, 2008

Gene therapy protocol at UCSD activates immune system in patients with leukemia

Researchers at UCSD developed a gene therapy protocol that successfully activated the immune system in six patients with chronic lymphocytic leukemia. The protocol introduced a gene with potential to activate an immune response and resulted in the production of antibodies reacting against leukemia cells.

SourceUniversity of California - San Diego·JournalProceedings of the National Academy of Sciences·DateFeb 11, 2008